Page last updated: 2024-09-05

phosphatidylcholines and l 743,872

phosphatidylcholines has been researched along with l 743,872 in 13 studies

Compound Research Comparison

Studies
(phosphatidylcholines)
Trials
(phosphatidylcholines)
Recent Studies (post-2010)
(phosphatidylcholines)
Studies
(l 743,872)
Trials
(l 743,872)
Recent Studies (post-2010) (l 743,872)
32,2044435,5931,72475849

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sims-McCallum, RP1
Bartlett, K; Batty, DS; Choo, E; Marra, F; Risovic, V; Sivak, O; Wasan, KM1
Perfect, JR1
Edwards, JE; Fu, Y; Ibrahim, AS; Spellberg, B1
Clemons, KV; Fernandez, B; Imai, J; Singh, G; Stevens, DA1
Andes, D; Gauthier, GM; Nork, TM; Prince, R1
Cornila, C; Fohrer, C; Fornecker, L; Herbrecht, R; Marinescu, C; Nivoix, Y1
Adler-Moore, J; Avanesian, V; Edwards, JE; Fu, Y; Ibrahim, AS; Schwartz, J; Spellberg, B1
Bartlett, K; Risovic, V; Rosland, M; Sivak, O; Wasan, KM1
Cheung, C; Feldmesser, M; Gialanella, P; Guo, Y1
Beltrame, A; Cerana, M; De Maria, A; Di Biagio, A; Pacini, D1
Cappelli, B; Castagnola, E; Cuzzubbo, D; Faraci, M; Lanino, E; Moresco, L; Moroni, C1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA1

Reviews

2 review(s) available for phosphatidylcholines and l 743,872

ArticleYear
Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
Antifungal combination treatment: a future perspective.
    International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Echinocandins; Forecasting; Humans; In Vitro Techniques; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols

2006

Trials

1 trial(s) available for phosphatidylcholines and l 743,872

ArticleYear
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2008

Other Studies

10 other study(ies) available for phosphatidylcholines and l 743,872

ArticleYear
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
    Journal of pharmaceutical sciences, 2004, Volume: 93, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley

2004
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Drug Combinations; Echinocandins; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mucormycosis; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Survival

2005
Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols

2005
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-01, Volume: 41, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Combinations; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure

2005
Comparison of antifungal treatments for murine fusariosis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Drug Combinations; Echinocandins; Fusarium; Kidney; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mycoses; Neutropenia; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols

2006
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Echinocandins; Galactose; Injections, Intravenous; Lipopeptides; Male; Mannans; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Tissue Distribution

2007
Development of candidemia on caspofungin therapy: a case report.
    Infection, 2006, Volume: 34, Issue:6

    Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Catheters, Indwelling; Cross Infection; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Lipopeptides; Male; Pancreaticoduodenectomy; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications

2006
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Female; Fluconazole; Fungemia; Humans; Ileostomy; Lipopeptides; Middle Aged; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Practice Guidelines as Topic

2007
Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3

    Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Lung Diseases, Fungal; Mitochondrial Diseases; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Syndrome; Transplantation, Homologous

2007